https://aimarketreport.com/ Logo

Percutaneous Nephrostomy Catheters Market

Percutaneous Nephrostomy Catheters Market Size, Share & Trends Analysis Report

Percutaneous Nephrostomy Catheters Market Size, Share & Trend Analysis 2029

Published
Report ID : AIMR 1417
Number of pages : 200
Published Date : May 2023
Category : Life Sciences
Delivery Timeline : 48 hrs

Global Percutaneous Nephrostomy Catheters Market is valued at US$ 390.7 Million in 2022 and it is expected to reach US$ 665.3 Million by 2029 with a CAGR of 7.9% over the forecast period.

Global Percutaneous Nephrostomy Catheters Market: Global Size, Trends, Competitive, and Historical & Forecast Analysis, 2023-2029- The market will expand due to increasing prevalence of urinary tract obstructions, growing aging population, and rising prevalence of chronic conditions.

Scope of Global Percutaneous Nephrostomy Catheters Market Report-

Percutaneous nephrostomy catheters are medical devices used to drain urine from the kidney to the outside of the body. They are inserted through the skin into the kidney, and are typically used when there is an obstruction or blockage that prevents urine from flowing out of the kidney naturally.

There are various types of percutaneous nephrostomy catheters, including straight, curved, and pigtail catheters. Percutaneous nephrostomy catheters can help diagnose kidney problems by allowing doctors to collect urine samples directly from the kidney. There are several devices used to insert and manage percutaneous nephrostomy catheters, including guidewires, sheaths, dilators, and drainage bags.

Percutaneous nephrostomy catheters have been used in medical practice since the 1950s, but have undergone significant advancements in design and technology in recent years.

There are various application used by urologists, interventional radiologists, and other healthcare professionals and the end-users of percutaneous nephrostomy catheters include hospitals, ambulatory surgery centers, and specialty clinics.

Covid-19 Impact on the Global Percutaneous Nephrostomy Catheters Market:

The Covid-19 pandemic has had a significant impact on the healthcare industry, including the percutaneous nephrostomy catheters market. While the demand for these devices has remained steady due to the continued need for diagnosis and treatment of urinary tract obstruction, the supply chain and manufacturing processes have been disrupted.

The lockdowns and travel restrictions imposed in various countries have made it challenging to procure raw materials and distribute finished products. Additionally, the pandemic has led to a shortage of healthcare professionals and increased workload, which has affected the usage of Percutaneous Nephrostomy Catheters.

However, the pandemic has also highlighted the importance of remote healthcare and telemedicine, which has led to increased adoption of these technologies for monitoring and managing patients who require Percutaneous Nephrostomy Catheters. The increased awareness of the benefits of remote healthcare may lead to a shift in the delivery of healthcare services in the future.

Key Players of Global Percutaneous Nephrostomy Catheters Market Report

The global percutaneous nephrostomy catheters market is driven by several key players, including

  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • Cook Medical
  • C.R. Bard
  • Teleflex Incorporated
  • AngioDynamics Inc.
  • Argon Medical Devices Inc.
  • Medline Industries Inc.
  • Merit Medical Systems Inc.
  • Cardinal Health Inc.
  • Coloplast Group
  • Olympus Corporation
  • Cure Medical LLC
  • Cogentix Medical Inc.
  • Stryker Corporation
  • UroMed (Hollister Incorporated)
  • Zephyr Surgical Implants
  • Optimed Medizinische Instrumente GmbH
  • Vascular Solutions Inc.
  • Vygon S.A.

Market Segmentation

By Tube Type:

  • Malecot
  • Pigtail
  • Balloon Retention
  • Others

By Material:

  • Silicone
  • Polyethylene
  • Polyurethane

By Application:

  • Urinary Tract Obstruction
  • Percutaneous Nephrolithotomy
  • Antegrade pyelography
  • Others

By End-User:

  • Hospitals & Ambulance Surgery Centers
  • Specialty Clinics
  • Others

By Regional & Country Level:

  • North America

    • U.S.
    • Canada
  • Europe

    • U.K.
    • France
    • Germany
    • Italy
  • Asia Pacific

    • China
    • Japan
    • India
    • Southeast Asia
  • Latin America

    • Brazil
    • Mexico
  • Middle East and Africa

    • GCC
    • Africa
    • Rest of Middle East and Africa

Revenue Generation Model:

The revenue generation model for the percutaneous nephrostomy catheters market involves the sale of these medical devices to healthcare facilities such as hospitals, ambulatory surgery centers, and specialty clinics. The manufacturers of the catheters supply them to distributors who then distribute them to the end-users. Revenue is generated through the direct sales of the devices, and it may also include additional revenue from maintenance, repair, and replacement services.

Supply Chain Analysis:

The supply chain for percutaneous nephrostomy catheters market involves various stages. It starts with the raw material procurement, which includes sourcing the necessary components for manufacturing the catheters. The next stage involves the manufacturing process, where the catheters are produced and assembled. Once manufactured, the catheters are then distributed to wholesalers or directly to healthcare facilities. The distribution stage includes logistics and transportation to ensure timely delivery. Finally, the catheters reach the end-users, such as hospitals or clinics, where they are used for patient care.

Value Chain Analysis:

The value chain for percutaneous nephrostomy catheters market encompasses the entire process from research and development to after-sales service. It begins with research and development efforts to improve the design, functionality, and safety of the catheters. The manufacturing stage follows, where the catheters are produced and quality-controlled. Marketing and distribution activities help create awareness, promote the products, and ensure their availability in the market. Sales processes involve reaching out to healthcare facilities and closing deals. Finally, after-sales services such as maintenance, repair, and replacement contribute to the overall value provided by the catheter manufacturers.

Market Drivers:

Increasing Prevalence of Urinary Tract Obstructions: The increasing prevalence of urinary tract obstructions is driven by several factors. First, lifestyle changes such as sedentary behavior and unhealthy dietary habits contribute to the formation of kidney stones, a common cause of obstructions.

For example; According to the National Kidney Foundation, kidney stones affect about one in 11 people in the United States, with a lifetime risk of approximately 9-10% in men and 5-6% in women. The prevalence of kidney stones varies in different parts of the world, with higher rates reported in some regions.

Growing Aging Population: The growing aging population is considered as a driver for the percutaneous nephrostomy catheters market as it leads to an increase in the incidence and prevalence of urinary tract obstructions, which are more common among older individuals. As the number of older individuals increases, there is a higher demand for age-related healthcare services, including the management of urinary tract obstructions, which requires the use of percutaneous nephrostomy catheters.

According to WHO; by 2030, one in six people in the world will be aged 60 years or over. At this time the share of the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion. By 2050, the world’s population of people aged 60 years and older will double (2.1 billion).

The number of persons aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million. Therefore, the growing aging population is expected to contribute to the growth of the percutaneous nephrostomy catheters market.

Market Restraints:

The availability of alternative treatment options is a significant restraint for the percutaneous nephrostomy catheters market. While these catheters are effective in managing urinary tract obstructions, there are alternative treatments available for certain conditions. For example; ureteral stenting and surgical interventions can be viable alternatives depending on the specific case and patient factors.

The availability of these alternatives gives healthcare providers and patients more treatment choices, which can impact the demand for percutaneous nephrostomy catheters. Additionally, the selection of the most appropriate treatment option depends on various factors, including the severity of the obstruction, patient preferences, and the expertise of healthcare professionals, further influencing the utilization of catheters.

Market Opportunities:

Increasing Minimally Invasive Procedures: The growing trend towards minimally invasive procedures presents an opportunity for percutaneous nephrostomy catheters. These catheters are a key component in minimally invasive techniques performed by urologists and interventional radiologists, offering benefits such as reduced patient discomfort and faster recovery times.

Rising Awareness and Education: Increasing awareness among healthcare providers and patients about the benefits of percutaneous nephrostomy catheters can drive market growth. Education initiatives, medical conferences, and published research can contribute to better understanding and acceptance of these catheters as an effective treatment option for urinary tract obstructions.

Market Trend Analysis:

Product and Technology Development Trends:

Integration of Advanced Imaging Technologies: The incorporation of advanced imaging technologies, such as fluoroscopy, ultrasound, and CT-guided procedures, is a significant trend in percutaneous nephrostomy catheters. These imaging modalities enable precise catheter placement and enhance the safety and efficacy of the procedures.

Product Enhancements for Safety and Patient Comfort: Manufacturers are focusing on product development to improve safety and patient comfort. This includes the use of softer and more flexible catheter materials, advanced locking mechanisms to prevent dislodgement, and features that reduce the risk of infection and other complications.

Customer Trends:

Demand for Personalized Treatment: Patients are increasingly seeking personalized treatment options that align with their specific needs and preferences. This trend extends to the use of percutaneous nephrostomy catheters, where patients may prefer catheters that offer better comfort, easier maintenance, and reduced invasiveness.

Shift towards Outpatient Settings: There is a growing preference for outpatient procedures, as they offer convenience and potentially lower healthcare costs. This trend can drive the adoption of percutaneous nephrostomy catheters in outpatient settings, where patients can receive the necessary care while minimizing hospital stays.

Market Competition Nature:

Competition in the percutaneous nephrostomy catheters market is driven by the presence of several key market players who strive to gain a competitive edge through various strategies. Key market players employ various strategies such as:

Product Innovation and Development: Key market players focus on continuous product innovation and development to introduce advanced catheter designs, materials, and features. These innovations aim to improve patient comfort, safety, and procedural outcomes, ultimately gaining a competitive advantage in the market.

Strategic Partnerships and Collaborations: Market players often engage in strategic partnerships and collaborations with other companies, research institutions, or healthcare providers to leverage their expertise, resources, and market reach. These collaborations can lead to shared knowledge, product enhancements, and expanded distribution networks.

Geographic Expansion: Key market players may pursue geographic expansion strategies to enter new markets and reach a wider customer base. This can involve establishing subsidiaries, distribution networks, or partnerships in different regions to enhance market presence and sales.

Marketing and Branding Initiatives: Effective marketing and branding strategies play a crucial role in creating brand awareness and capturing market share. Key market players invest in marketing campaigns, digital presence, and educational initiatives to promote their products, build brand loyalty, and differentiate themselves from competitors.

Geography Analysis:

North America:

North America is one of the largest markets for percutaneous nephrostomy catheters due to the presence of a well-established healthcare infrastructure, increasing prevalence of kidney diseases, and rising adoption of minimally invasive procedures. The U.S. is the major contributor to the market growth in the region due to the increasing number of people suffering from kidney stones and urinary tract infections.

For example; The Centers for Disease Control and Prevention (CDC) estimates that 1 in 7 adults in the United States, or about 15% of the adult population, have Chronic Kidney Disease (CKD). And the United States Renal Data System (USRDS) reports that in 2020, there were approximately 776,000 individuals living with ESRD in the United States.

In addition, the availability of reimbursement policies and favorable healthcare regulations is also driving the growth of the market in North America. The region is witnessing an increasing trend towards the adoption of advanced and innovative medical devices, which is expected to drive the demand for percutaneous nephrostomy catheters in the coming years.

Furthermore, key market players in the region are focusing on expanding their market presence through various strategies such as product launches, partnerships, and mergers and acquisitions. For example; in 2021, Cook Medical launched its advanced percutaneous nephrostomy catheter, which is designed to reduce the risk of urinary tract infections and provide better patient outcomes.

Europe:

In Europe, the market is primarily driven by the increasing prevalence of urinary tract obstructions and related disorders, along with the growing elderly population. In 2020, the share of the population aged 65 years and older in the European Union was approximately 20.7%. This number is projected to rise significantly in the coming decades. The demand for percutaneous nephrostomy catheters is also driven by the availability of advanced healthcare facilities and well-established reimbursement policies.

Several European countries such as Germany, France, and the UK have well-established healthcare systems that offer advanced treatment options for urological disorders. As a result, the demand for percutaneous nephrostomy catheters is high in these countries. Furthermore, the increasing prevalence of chronic diseases such as diabetes and obesity is also expected to drive the market growth in Europe.

Key Benefits of Global Percutaneous Nephrostomy Catheters Market Report–

  • Global Percutaneous Nephrostomy Catheters Market report covers in-depth historical and forecast analysis.
  • Global Percutaneous Nephrostomy Catheters Market research report provides detailed information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market Opportunities, Competitive Analysis, and Regional and Country Level.
  • Global Percutaneous Nephrostomy Catheters Market report helps to identify opportunities in the marketplace.
  • Global Percutaneous Nephrostomy Catheters Market report covers extensive analysis of emerging trends and competitive landscape.

 

SUMMARY
VishalSawant
Vishal Sawant
Business Development
vishal@brandessenceresearch.com
+91 8830 254 358
Segmentation
Segments

By Tube Type:

  • Malecot
  • Pigtail
  • Balloon Retention
  • Others

By Material:

  • Silicone
  • Polyethylene
  • Polyurethane

By Application:

  • Urinary Tract Obstruction
  • Percutaneous Nephrolithotomy
  • Antegrade pyelography
  • Others

By End-User:

  • Hospitals & Ambulance Surgery Centers
  • Specialty Clinics
  • Others
Country
Regions and Country

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Sweden
  • Netherlands
  • Turkey
  • Switzerland
  • Belgium
  • Rest of Europe

Asia-Pacific

  • South Korea
  • Japan
  • China
  • India
  • Australia
  • Philippines
  • Singapore
  • Malaysia
  • Thailand
  • Indonesia
  • Rest of APAC

Latin America

  • Mexico
  • Colombia
  • Brazil
  • Argentina
  • Peru
  • Rest of South America

Middle East and Africa

  • Saudi Arabia
  • UAE
  • Egypt
  • South Africa
  • Rest of MEA
Company
Key Players
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • Cook Medical
  • C.R. Bard
  • Teleflex Incorporated
  • AngioDynamics Inc.
  • Argon Medical Devices Inc.
  • Medline Industries Inc.
  • Merit Medical Systems Inc.
  • Cardinal Health Inc.
  • Coloplast Group
  • Olympus Corporation
  • Cure Medical LLC
  • Cogentix Medical Inc.
  • Stryker Corporation
  • UroMed (Hollister Incorporated)
  • Zephyr Surgical Implants
  • Optimed Medizinische Instrumente GmbH
  • Vascular Solutions Inc.
  • Vygon S.A.

+44-1173181773

sales@brandessenceresearch.com

We are always looking to hire talented individuals with equal and extraordinary proportions of industry expertise, problem solving ability and inclination interested? please email us hr@brandessenceresearch.com

JOIN US

LONDON OFFICE

AI® Market Research and Consulting Pvt ltd.

124, City Road, London EC1V 2NX

FOLLOW US

Twitter
Facebook
LinkedIn
Skype
YouTube

CONTACT US

1-888-853-7040 - U.S. (TOLL FREE)+44-1173181773 - U.K. OFFICE+91-7447409162 - INDIA OFFICE

© Copyright 2025-26 AI® Market Research and Consulting. All Rights Reserved | Designed by AI® Market

PaymentModes